Abstract
An ultraviolet spectrophotometric procedure for the micro determination of carbamazepine in blood is described which is based on the original 9-methyl-acridine method proposed by Beyer, K.H. and Klinge, K. (1969) (Arzneim-Forsch. 19, 1759–1760). Carbamazepine is extracted from blood with dichloromethane, which is then washed with alkali and acid. An aliquot of the extractant is evaporated to dryness and the residue heated briefly with hydrochloric acid at 150°C. Following removal of non-specific interference with n-heptane, the absorbance of the acid catalysed rearrangement product (9-methylacridine) is determined at 258 nm. The resulting procedure is rapid, reliable, sensitive and specific. It requires 100–200 μl sample for a single estimation and has a detection threshold of less than 0.1 mg/100 ml. It is concluded that the method is suitable for routine clinical use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
